Skip to main content

Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary Syndrome.

Publication ,  Journal Article
Chan, MY; Neely, ML; Roe, MT; Goodman, SG; Erlinge, D; Cornel, JH; Winters, KJ; Jakubowski, JA; Zhou, C; Fox, KAA; Armstrong, PW; White, HD ...
Published in: Clin Chem
July 2017

BACKGROUND: There are conflicting data on whether changes in N-terminal pro-B-type natriuretic peptide (NT-proBNP) and high-sensitivity C-reactive protein (hs-CRP) concentrations between time points (delta NT-proBNP and hs-CRP) are associated with a change in prognosis. METHODS: We measured NT-proBNP and hs-CRP at 3 time points in 1665 patients with non-ST-segment elevation acute coronary syndrome (NSTEACS). Cox proportional hazards was applied to the delta between temporal measurements to determine the continuous association with cardiovascular events. Effect estimates for delta NT-proBNP and hs-CRP are presented per 40% increase as the basic unit of temporal change. RESULTS: Median NT-proBNP was 370.0 (25th, 75th percentiles, 130.0, 996.0), 340.0 (135.0, 875.0), and 267.0 (111.0, 684.0) ng/L; and median hs-CRP was 4.6 (1.7, 13.1), 1.9 (0.8, 4.5), and 1.8 (0.8, 4.4) mg/L at baseline, 30 days, and 6 months, respectively. The deltas between baseline and 6 months were the most prognostically informative. Every +40% increase of delta NT-proBNP (baseline to 6 months) was associated with a 14% greater risk of cardiovascular death (adjusted hazard ratio (HR) 1.14, 95% CI, 1.03-1.27) and with a 14% greater risk of all-cause death (adjusted HR 1.14, 95% CI, 1.04-1.26), while every +40% increase of delta hs-CRP (baseline to 6 months) was associated with a 9% greater risk of the composite end point (adjusted HR 1.09, 95% CI, 1.02-1.17) and a 10% greater risk of myocardial infarction (adjusted HR 1.10, 95%, CI 1.00-1.20). CONCLUSIONS: Temporal changes in NT-proBNP and hs-CRP are quantitatively associated with future cardiovascular events, supporting their role in dynamic risk stratification of NSTEACS. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov identifier NCT00699998.

Duke Scholars

Published In

Clin Chem

DOI

EISSN

1530-8561

Publication Date

July 2017

Volume

63

Issue

7

Start / End Page

1214 / 1226

Location

England

Related Subject Headings

  • Time Factors
  • Risk Factors
  • Proteogenomics
  • Natriuretic Peptide, Brain
  • Myocardial Infarction
  • Middle Aged
  • Male
  • Humans
  • General Clinical Medicine
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chan, M. Y., Neely, M. L., Roe, M. T., Goodman, S. G., Erlinge, D., Cornel, J. H., … TRILOGY ACS Investigators, . (2017). Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary Syndrome. Clin Chem, 63(7), 1214–1226. https://doi.org/10.1373/clinchem.2016.265272
Chan, Mark Y., Megan L. Neely, Matthew T. Roe, Shaun G. Goodman, David Erlinge, Jan H. Cornel, Kenneth J. Winters, et al. “Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary Syndrome.Clin Chem 63, no. 7 (July 2017): 1214–26. https://doi.org/10.1373/clinchem.2016.265272.
Chan MY, Neely ML, Roe MT, Goodman SG, Erlinge D, Cornel JH, et al. Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary Syndrome. Clin Chem. 2017 Jul;63(7):1214–26.
Chan, Mark Y., et al. “Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary Syndrome.Clin Chem, vol. 63, no. 7, July 2017, pp. 1214–26. Pubmed, doi:10.1373/clinchem.2016.265272.
Chan MY, Neely ML, Roe MT, Goodman SG, Erlinge D, Cornel JH, Winters KJ, Jakubowski JA, Zhou C, Fox KAA, Armstrong PW, White HD, Prabhakaran D, Ohman EM, Huber K, TRILOGY ACS Investigators. Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary Syndrome. Clin Chem. 2017 Jul;63(7):1214–1226.

Published In

Clin Chem

DOI

EISSN

1530-8561

Publication Date

July 2017

Volume

63

Issue

7

Start / End Page

1214 / 1226

Location

England

Related Subject Headings

  • Time Factors
  • Risk Factors
  • Proteogenomics
  • Natriuretic Peptide, Brain
  • Myocardial Infarction
  • Middle Aged
  • Male
  • Humans
  • General Clinical Medicine
  • Female